252 related articles for article (PubMed ID: 25630553)
1. The incidence and risk factors of resistant E. coli infections after prostate biopsy under fluoroquinolone prophylaxis: a single-centre experience with 2215 patients.
Kandemir Ö; Bozlu M; Efesoy O; Güntekin O; Tek M; Akbay E
J Chemother; 2016 Aug; 28(4):284-8. PubMed ID: 25630553
[TBL] [Abstract][Full Text] [Related]
2. Prevalence and characteristics of fecal antimicrobial-resistant Escherichia coli in a cohort of Japanese men undergoing prostate biopsy.
Kamei J; Yagihara Y; Kume H; Horiuchi T; Sato T; Nakagawa T; Fujimura T; Fukuhara H; Moriya K; Homma Y
Int J Urol; 2017 Apr; 24(4):295-300. PubMed ID: 28222483
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of fluoroquinolone-resistant Escherichia coli before and incidence of acute bacterial prostatitis after prostate biopsy.
Minamida S; Satoh T; Tabata K; Kimura M; Tsumura H; Kurosaka S; Matsumoto K; Fujita T; Iwamura M; Baba S
Urology; 2011 Dec; 78(6):1235-9. PubMed ID: 21908030
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of fluoroquinolone-resistant rectal flora in patients undergoing transrectal ultrasound-guided prostate needle biopsy: A prospective multicenter study.
Chung HS; Hwang EC; Yu HS; Jung SI; Lee SJ; Lim DH; Cho WJ; Choe HS; Lee SJ; Park SW
Int J Urol; 2018 Mar; 25(3):278-283. PubMed ID: 29241300
[TBL] [Abstract][Full Text] [Related]
5. The incidence of fluoroquinolone resistant infections after prostate biopsy--are fluoroquinolones still effective prophylaxis?
Feliciano J; Teper E; Ferrandino M; Macchia RJ; Blank W; Grunberger I; Colon I
J Urol; 2008 Mar; 179(3):952-5; discussion 955. PubMed ID: 18207185
[TBL] [Abstract][Full Text] [Related]
6. Fluoroquinolone-resistant E. coli in intestinal flora of patients undergoing transrectal ultrasound-guided prostate biopsy--should we reassess our practices for antibiotic prophylaxis?
Steensels D; Slabbaert K; De Wever L; Vermeersch P; Van Poppel H; Verhaegen J
Clin Microbiol Infect; 2012 Jun; 18(6):575-81. PubMed ID: 21958149
[TBL] [Abstract][Full Text] [Related]
7. Antibiotic prophylaxis with intravenous ceftriaxone and fluoroquinolone reduces infectious complications after transrectal ultrasound-guided prostatic biopsy.
Lee C; You D; Jeong IG; Hong JH; Choo MS; Ahn H; Ahn TY; Kim CS
Korean J Urol; 2015 Jun; 56(6):466-72. PubMed ID: 26078845
[TBL] [Abstract][Full Text] [Related]
8. Selective culture of Escherichia coli to prevent infective complications of transrectal ultrasound-guided prostate biopsy: Clinical efficacy and analysis of characteristics of quinolone-resistant Escherichia coli.
Hiyama Y; Takahashi S; Uehara T; Ichihara K; Hashimoto J; Matsukawa M; Taguchi K; Kunishima Y; Hotta H; Yanase M; Itoh N; Hirose T; Takeyama K; Tachiki H; Masumori N
Int J Urol; 2019 Jun; 26(6):655-660. PubMed ID: 30959574
[TBL] [Abstract][Full Text] [Related]
9. Sepsis due to fluoroquinolone-resistant Escherichia coli after transrectal ultrasound-guided prostate needle biopsy.
Young JL; Liss MA; Szabo RJ
Urology; 2009 Aug; 74(2):332-8. PubMed ID: 19464041
[TBL] [Abstract][Full Text] [Related]
10. Outbreak of fluoroquinolone-resistant Escherichia coli infections after transrectal ultrasound-guided biopsy of the prostate.
Dumford D; Suwantarat N; Bhasker V; Kundrapu S; Zabarsky TF; Drawz P; Zhu H; Donskey CJ
Infect Control Hosp Epidemiol; 2013 Mar; 34(3):269-73. PubMed ID: 23388361
[TBL] [Abstract][Full Text] [Related]
11. Trial Comparing a Combined Regimen of Amikacin and Ciprofloxacin to Ciprofloxacin Alone as Transrectal Prostate Biopsy Prophylaxis in the Era of High Fluoroquinolone-Resistant Rectal Flora.
Son KC; Chung HS; Jung SI; Kim MS; Hwang EC; Kim JW; Kwon DD
J Korean Med Sci; 2018 Apr; 33(15):e113. PubMed ID: 29629517
[TBL] [Abstract][Full Text] [Related]
12. Impact of selective media for detecting fluoroquinolone-insusceptible/extended-spectrum beta-lactamase-producing Escherichia coli before transrectal prostate biopsy.
Sadahira T; Wada K; Araki M; Ishii A; Watanabe T; Nasu Y; Tsugawa M; Takenaka T; Nasu Y; Kumon H
Int J Urol; 2017 Dec; 24(12):842-847. PubMed ID: 28929546
[TBL] [Abstract][Full Text] [Related]
13. Emergence of fluoroquinolone-resistant Escherichia coli as cause of postprostate biopsy infection: implications for prophylaxis and treatment.
Zaytoun OM; Vargo EH; Rajan R; Berglund R; Gordon S; Jones JS
Urology; 2011 May; 77(5):1035-41. PubMed ID: 21420152
[TBL] [Abstract][Full Text] [Related]
14. Escherichia coli bloodstream infection after transrectal ultrasound-guided prostate biopsy: implications of fluoroquinolone-resistant sequence type 131 as a major causative pathogen.
Williamson DA; Roberts SA; Paterson DL; Sidjabat H; Silvey A; Masters J; Rice M; Freeman JT
Clin Infect Dis; 2012 May; 54(10):1406-12. PubMed ID: 22419681
[TBL] [Abstract][Full Text] [Related]
15. Modification of antimicrobial prophylaxis based on rectal culture results to prevent fluoroquinolone-resistant Escherichia coli infections after prostate biopsy.
Suwantarat N; Dumford DM; Ponce-Terashima R; Kundrapu S; Zabarsky TF; Zhu H; Donskey CJ
Infect Control Hosp Epidemiol; 2013 Sep; 34(9):973-6. PubMed ID: 23917913
[TBL] [Abstract][Full Text] [Related]
16. Ciprofloxacin resistance in the faecal carriage of patients undergoing transrectal ultrasound guided prostate biopsy.
Taylor S; Margolick J; Abughosh Z; Goldenberg SL; Lange D; Bowie WR; Bell R; Roscoe D; Machan L; Black P
BJU Int; 2013 May; 111(6):946-53. PubMed ID: 23464844
[TBL] [Abstract][Full Text] [Related]
17. Comparative Effectiveness of Single versus Combination Antibiotic Prophylaxis for Infections after Transrectal Prostate Biopsy.
Marino K; Parlee A; Orlando R; Lerner L; Strymish J; Gupta K
Antimicrob Agents Chemother; 2015 Dec; 59(12):7273-5. PubMed ID: 26369958
[TBL] [Abstract][Full Text] [Related]
18. Risk factors for fluoroquinolone-resistant Escherichia coli in adults with community-onset febrile urinary tract infection.
van der Starre WE; van Nieuwkoop C; Paltansing S; van't Wout JW; Groeneveld GH; Becker MJ; Koster T; Wattel-Louis GH; Delfos NM; Ablij HC; Leyten EM; Blom JW; van Dissel JT
J Antimicrob Chemother; 2011 Mar; 66(3):650-6. PubMed ID: 21123286
[TBL] [Abstract][Full Text] [Related]
19. Occurrence of infection following prostate biopsy procedures in Japan: Japanese Research Group for Urinary Tract Infection (JRGU) - a multi-center retrospective study.
Togo Y; Kubo T; Taoka R; Hiyama Y; Uehara T; Hashimoto J; Kurimura Y; Takahashi S; Tsukamoto T; Miyazaki J; Nishiyama H; Kira S; Kiyota H; Yazawa S; Niwa N; Hongo H; Oya M; Kato T; Yasuda M; Deguchi T; Ishikawa K; Hoshinaga K; Matsumoto M; Shigemura K; Tanaka K; Arakawa S; Fujisawa M; Wada K; Uehara S; Watanabe T; Kumon H; Kobayashi K; Matsubara A; Matsumoto M; Sho T; Hamasuna R; Matsumoto T; Hayami H; Nakagawa M; Yamamoto S
J Infect Chemother; 2014 Apr; 20(4):232-7. PubMed ID: 24594451
[TBL] [Abstract][Full Text] [Related]
20. Antibiotic susceptibility of intestinal Escherichia coli in men undergoing transrectal prostate biopsies: a prospective, registered, multicentre study.
Knaapila J; Kallio H; Hakanen AJ; Syvänen K; Ettala O; Kähkönen E; Lamminen T; Seppänen M; Jambor I; Rannikko A; Riikonen J; Munukka E; Eerola E; Gunell M; Boström PJ
BJU Int; 2018 Aug; 122(2):203-210. PubMed ID: 29533507
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
